An observational study in Premature Birth, Cerebral Palsy and Neurodevelopmental Disorders, sponsored by University Hospital, Geneva. Recruiting at 1 site in Switzerland. Open to participants aged 35 Weeks to 1 Year, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-15.
Sponsored by University Hospital, Geneva · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Premature Birth with a site in Switzerland — 12 open to participants now, 14 under way, none of them phase 3. Premature Birth · Switzerland.
Among the 34 studies in Premature Birth with a site in Switzerland, this one is the 5th largest by planned enrollment of the 14 observational ones that give a count, is one of 3 that started in 2023, is one of 14 observational ones, reaches primary completion later than 7 of the 13 other live ones, and was the 25th registered.
2,556 studies on the registry are indexed under Premature Birth; 504 are open to participants now.
Browse Premature Birth studies →12 of the 34 studies in Premature Birth with a site in Switzerland are open now. Recruiting first, the newest first:
Rea Diagnostics SA · Sites in Switzerland
Ages 18+ · Women only
University of Zurich · Sites in Switzerland
Ages up to 4 wk
Riccardo Pfister · Sites in Switzerland
Ages 14 days–14 days · Healthy volunteers
Henner Hanssen · Sites in Switzerland
Ages 6–12 · Healthy volunteers
Insel Gruppe AG, University Hospital Bern · Sites in Switzerland
Healthy volunteers
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.
This study: 35 Weeks to 1 Year · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 348 is above the median of 120 across 809 observational studies indexed under Premature Birth.
Median enrollment 57 across the 20 interventional studies, 168 across the 14 observational. Of the 19 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 34 have an industry lead sponsor. The 10 most frequent:
University Hospital, Geneva is the lead sponsor of 379 studies on the registry; 70 are open to participants now.
University Hospital, Geneva has 4 studies filed under Premature Birth — fewer than ten, so there is no comparison to draw.
2 of the studies in Premature Birth with a site in Switzerland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07237139University of ZurichPulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation | 2026-12-31 |
| NCT07307365Rea Diagnostics SAEvaluation of the Clinical Performance of the PremaSure Kit to Assess Premature Delivery Risk in Symptomatic Pregnant Patients | 2027-03 |
Add all 2 to your calendar (.ics) → With an account.
Among the 34 studies in Premature Birth with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This project focuses on motor development, muscle growth and muscle activity. Using advanced, instrumented tests such as , the link between muscles and the movement characteristics will be studied. In addition, the evolution of these neuro-biomechanical determinants during the first year of life will be investigated. The examinations are planned for a group of high-risk infants (e.g. premature birth, cases of asphyxia, etc.) compared with a group of infants with typical development.
Background and rationale:
Prematurity and the associated causes of perinatal brain damage, as well as neonatal stroke and birth asphyxia, are major risk factors for neurodevelopmental disorders appearing from birth. In addition, these neuromotor disorders resulting from impaired brain development appear progressively over the course of the first year, affecting early movement and muscle growth. Therefore, early diagnosis and motor therapy are essential to improve long-term neurodevelopmental outcomes. However, in order to provide adequate strategies for these high-risk infants, it is crucial to identify the determinants of potential neuromotor deficits and their consequences on early motor behavior and developmental trajectory during the first year of life. A multimodal tool is needed to reveal the early neuro-biomechanical determinants of motor behavior in infants at high risk of neurodevelopmental disorders.
Objective(s):
Outcome(s):
Methodology
The current study is a national, single center (Geneva University Hospitals), observational study. This observational research will perform both cross-sectional and longitudinal data collection for cohorts of live-born infants.
The study population for this study will include children, i.e., neonates and infants between the age of 35-36 weeks of gestational age to 12 months of (corrected) age. Further, two main groups of children will be included, (a) typically developing (TD) children and (b) children at high-risk for neurodevelopmental impairments. The TD children will be used as a control group.
Procedure
Multiple study visits are planned for longitudinal data collection within the first year of life, i.e. a time of term age, at 3 months, at 6 months and 12 months of age. For the preterms, the investigators also plan to perform an assessment in the neonatal period, i.e. 35-36 weeks of gestation.
The duration of each visit session will be around 90 minutes per participant, providing also time for feeding moments and adaptation of the infant to the new environment. The visit in the neonatal period will be organized at the Neonatology Unit at HUG (Geneva University Hospitals). All visits from the term (equivalent) age will be organized in the Kinesiology Laboratory at the HUG.
In general, clinical data such as birth information, structural brain MRI and developmental assessments will be derived from the medical records.
The main procedures during each research visit are:
Preterm or a term born Infants with detectable risk factors for neurodevelopmental impairments will be enrolled
Inclusion \& exclusion criteria for group of high-risk infants:
Inclusion \& exclusion criteria for group of typically developing children:
Other: No Intervention
Other: No Intervention
No intervention
General Movement Assessment
Observation of general movements following the Prechtl's General Movement Assessment, interpreted by observing age-specific general movement components and extracting the Motor Optimality Score (0-12, the higher, the better outcome)
Time frame: 35-36 weeks of gestation; term equivalent age, 3 months (corrected) age
Hammersmith Neonatal/Infant Neurological Examination
Neurological assessment for different domains such as muscle tone, postures, movements and reflexes . Resulting in total scores (0-78) which can be compared to norm values, and higher scores indicate better outcome.
Time frame: 35-36 weeks of gestation; term equivalent age, 3 months (corrected) age, 6 months (corrected) age and 12 months (corrected) age.
Change in muscle morphology size
The size of the lower leg muscles defined by freehand ultrasound
Time frame: 35-36 weeks of gestation; term equivalent age, 3 months (corrected) age, 6 months (corrected) age and 12 months (corrected) age.
Change in muscle morphology length
The length of the lower leg muscles defined by freehand ultrasound
Time frame: 35-36 weeks of gestation; term equivalent age, 3 months (corrected) age, 6 months (corrected) age and 12 months (corrected) age.
Change in muscle activity
Investigation of the muscle activity during spontaneous, whole body movements by using surface electromyography.
Time frame: 35-36 weeks of gestation; term equivalent age, 3 months (corrected) age, 6 months (corrected) age and 12 months (corrected) age.
Change in motor behaviour
Investigation movement quality/quantify during spontaneous, whole body movements by using reflective markers.
Time frame: 35-36 weeks of gestation; term equivalent age, 3 months (corrected) age, 6 months (corrected) age and 12 months (corrected) age.
Bayley Scales of Infant and Toddler Development - Version III
Standardized neurodevelopmental test of gross and fine motor skills. Higher scores indicate better outcome.
Time frame: 3 months (corrected) age, 6 months (corrected) age and 12 months (corrected) age.
Alberta Infant Motor Scale (AIMS)
Assessment of gross motor development during prone, supine, sitting and standing. Scores from 0-60. Higher scores indicate better outcome.
Time frame: 3 months (corrected) age, 6 months (corrected) age and 12 months (corrected) age.
Magnetic resonance imaging of the brain: classification
Qualitatively assessment on the MRI classification system by Himmelman et al. to classify the nature of brain abnormalities.
Time frame: up to 4 weeks post-term age
Magnetic resonance imaging of the brain: quantification
Qualitatively assessment on the MRI classification system by quantitative assessment using the Kidokoro scoring system to classify the extent of white and grey matter abnormalities. Total global scores were classified as normal (0-3), mild (4-7), moderate (8-11), or severe (≥12) brain abnormalities.
Time frame: up to 4 weeks post-term age
Plan to share: Yes — The data will be made available upon publication via online repository (yareta or zenodo)
Time frame: Upon publication
Started Oct 2023 (actual). Primary completion is estimated for Mar 2026, 29 months after the start.
Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 29 months is below that.
Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.